Bank of New York Mellon’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,645
| Closed | -$9K | – | 4382 |
|
|
2020
Q4 | $9K | Hold |
13,645
| – | – | ﹤0.01% | 4204 |
|
|
2020
Q3 | $7K | Hold |
13,645
| – | – | ﹤0.01% | 4106 |
|
|
2020
Q2 | $9K | Hold |
13,645
| – | – | ﹤0.01% | 4070 |
|
|
2020
Q1 | $10K | Hold |
13,645
| – | – | ﹤0.01% | 4079 |
|
|
2019
Q4 | $21K | Hold |
13,645
| – | – | ﹤0.01% | 4153 |
|
|
2019
Q3 | $20K | Hold |
13,645
| – | – | ﹤0.01% | 4174 |
|
|
2019
Q2 | $18K | Sell |
13,645
-112,618
| -89% | -$149K | ﹤0.01% | 4182 |
|
|
2019
Q1 | $330K | Buy |
126,263
+7,200
| +6% | +$18.8K | ﹤0.01% | 3712 |
|
|
2018
Q4 | $196K | Buy |
119,063
+43,877
| +58% | +$72.2K | ﹤0.01% | 3856 |
|
|
2018
Q3 | $364K | Buy |
75,186
+56
| +0.1% | +$271 | ﹤0.01% | 3760 |
|
|
2018
Q2 | $469K | Buy |
75,130
+3,155
| +4% | +$19.7K | ﹤0.01% | 3657 |
|
|
2018
Q1 | $598K | Buy |
71,975
+2,074
| +3% | +$17.2K | ﹤0.01% | 3490 |
|
|
2017
Q4 | $714K | Sell |
69,901
-11,716
| -14% | -$120K | ﹤0.01% | 3424 |
|
|
2017
Q3 | $747K | Buy |
81,617
+22,363
| +38% | +$205K | ﹤0.01% | 3383 |
|
|
2017
Q2 | $433K | Sell |
59,254
-587
| -1% | -$4.29K | ﹤0.01% | 3666 |
|
|
2017
Q1 | $431K | Buy |
59,841
+16,191
| +37% | +$117K | ﹤0.01% | 3605 |
|
|
2016
Q4 | $256K | Buy |
43,650
+11,805
| +37% | +$69.2K | ﹤0.01% | 3822 |
|
|
2016
Q3 | $210K | Sell |
31,845
-6,163
| -16% | -$40.6K | ﹤0.01% | 3883 |
|
|
2016
Q2 | $353K | Buy |
38,008
+16,046
| +73% | +$149K | ﹤0.01% | 3680 |
|
|
2016
Q1 | $237K | Buy |
21,962
+5,417
| +33% | +$58.5K | ﹤0.01% | 3730 |
|
|
2015
Q4 | $237K | Buy |
16,545
+4,832
| +41% | +$69.2K | ﹤0.01% | 3797 |
|
|
2015
Q3 | $246K | Buy |
+11,713
| New | +$246K | ﹤0.01% | 3794 |
|